MONOCRYL POLIGLECAPRONE 25 SUTURE UNKNOWN PRODUCT
Report
- Report Number
- 2210968-2021-07304
- Event Type
- Injury
- Date Received
- August 12, 2021
- Date of Event
- January 1, 2020
- Report Date
- August 3, 2021
- Manufacturer
- ETHICON INC.
- Product Code
- GAN
- PMA / PMN Number
- K960653
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- OTHER
Narratives
(B)(4). IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. ATTEMPTS ARE BEING MADE TO CLARIFY THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE SURGEON BELIEVE THAT ANY OF THE ETHICON PRODUCTS INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POST-OPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE? DOES THE SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH ANY OF THE ETHICON PRODUCTS USED IN THIS PROCEDURE? IF SO, PLEASE PROVIDE DETAILS. WERE THE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. PATIENT DEMOGRAPHICS? THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. COMPONENT CODE: (B)(4) DEVICE NOT RETURNED. THE SINGLE COMPLAINT WAS REPORTED WITH MULTIPLE EVENTS. THERE ARE NO ADDITIONAL DETAILS REGARDING THE ADDITIONAL EVENTS. RELATED EVENTS CAPTURED VIA 2210968-2021-07295, 2210968-2021-07296, 2210968-2021-07297, 2210968-2021-07298, 2210968-2021-07299, 2210968-2021-07300, 2210968-2021-07301, 2210968-2021-07303, 2210968-2021-07305, 2210968-2021-07306 ,2210968-2021-07307, 2210968-2021-07308, 2210968-2021-07309, 2210968-2021-07310, 2210968-2021-07311, 2210968-2021-07312, 2210968-2021-07313, 2210968-2021-07314, 2210968-2021-07315, 2210968-2021-07316, 2210968-2021-07317, 2210968-2021-07318, 2210968-2021-07319, 2210968-2021-07320, 2210968-2021-07321, 2210968-2021-07322. CITATION: SAGEPUB.COM/JOURNALS-PERMISSIONS DOI: 10.1177/2192568219868200 JOURNALS.SAGEPUB.COM/HOME/GSJ.
TITLE: REDUCING SURGICAL SITE INFECTION IN PEDIATRIC SCOLIOSIS SURGERY: A MULTIDISCIPLINARY IMPROVEMENT PROGRAM AND PROSPECTIVE 4-YEAR AUDIT. THE OBJECTIVES OF THIS STUDY IS TO EVALUATE A MULTIDISCIPLINARY LED, STRUCTURED PROTOCOL FOR REDUCING SURGICAL SITE INFECTIONS (SSIS) IN PEDIATRIC SCOLIOSIS SURGERY. IT IS A SINGLE-CENTER PROSPECTIVE COHORT STUDY. CONSULTANT SURGEONS OPERATED WITH THE ASSISTANCE OF A SENIOR SPINAL FELLOW, OR MORE RARELY WITH A SECOND CONSULTANT. LENGTH OF SURGERY WAS NOT DIRECTLY AUDITED, BUT THE NUMBER OF OPERATED LEVELS WAS USED AS A SURROGATE MARKER FOR DURATION. WOUND CLOSURE WAS PERFORMED WITH VICRYL SUTURES(ETHICON) TO THE SUBCUTANEOUS TISSUES. REGARDING SKIN CLOSURE, FOR ADOLESCENT IDIOPATHIC SCOLIOSIS CASES SUBCUTANEOUS 3.0 MONOCRYL SUTURES(ETHICON) WITH SKIN GLUE. FOR NEUROMUSCULAR CASES 2.0 NYLON SUTURES(ETHICON) INTERRUPTED SUTURES WERE APPLIED, ALSO WITH GLUE. INCLUDING THE USE OF THE FIBRIN-BASED SURGIFLO (ETHICON BIOSURGERY, LIMERICK, IRELAND) AT THE SCREW INSERTION POINTS AND AD HOC THROUGHOUT THE OPERATION WHEN BLEEDING IS ENCOUNTERED. REPORTED COMPLICATIONS INCLUDED (B)(6)YEARS OLD FEMALE- SURGICAL SITE INFECTION. (B)(6) YEARS OLD FEMALE- SURGICAL SITE INFECTION, (B)(6)YEARS OLD FEMALE - SURGICAL SITE INFECTION, (B)(6) YEARS OLD FEMALE -SURGICAL SITE INFECTION, (B)(6) YEARS OLD FEMALE - SURGICAL SITE INFECTION, (B)(6) YEARS OLD FEMALE - SURGICAL SITE INFECTION, (B)(6)YEARS OLD FEMALE - SURGICAL SITE INFECTION, (B)(6) YEARS OLD FEMALE - SURGICAL SITE INFECTION (B)(6)YEARS OLD FEMALE - SURGICAL SITE INFECTION. IN CONCLUSION A MULTIDISCIPLINARY APPROACH WITH STANDARDIZED MEASURES SIGNIFICANTLY REDUCED SSIS IN THE UNITS PEDIATRIC SCOLIOSIS SURGERY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1212382 | MONOCRYL POLIGLECAPRONE 25 SUTURE UNKNOWN PRODUCT | SUTURE, ABSORBABLE, SYNTHETIC | GAN | ETHICON INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 14 YR | Required Intervention |